Release Date: 23/12/09 09:45 Summary: LUDOWICI ACQUISITION AND CAPITAL RAISING Price Sensitive: Yes Download Document 43.4KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status